Maa: Kanada
Kieli: englanti
Lähde: Health Canada
ANISTREPLASE
WELLSPRING PHARMACEUTICAL CANADA CORP
B01AD03
ANISTREPLASE
30UNIT
POWDER FOR SOLUTION
ANISTREPLASE 30UNIT
INTRAVENOUS
30
Schedule D
THROMBOLYTIC AGENTS
Active ingredient group (AIG) number: 0122566002; AHFS:
CANCELLED POST MARKET
2009-02-23